CXCL1 and neoplasm: CXCL1 showed elevated expression in CRC tissues that correlated with more advanced clinicopathological features, such as larger tumor size, deeper invasion, the presence of lymph node metastasis, and higher clinical stage, thus is being considered a potential biomarker of tumor progression.